Calix awarded $1m

to develop Biotechnology manufacturing capability in Australia.

Audrey Barucchi \ June 29, 2021

We are pleased to announce we have been awarded the maximum $1m grant under the Australian Government’s Manufacturing Modernisation Fund (MMF) to develop and transform our Biotech manufacturing capability at our Bacchus Marsh facility in Victoria.

  • The MMF support will assist Calix to transform the development of, and establish an advanced manufacturing capacity for, bio-active materials for crop protection, marine coatings, and health and pharmaceuticals applications at its Bacchus Marsh facility in Victoria.
  • The funding will support Calix’s recent capital raising for additional lab and production facilities for its Biotech line of business, and free up current capacity constraints on its Advanced Battery Materials program, which currently shares many common facilities.

“We are delighted to have been awarded the maximum MMF grant of $1m to help advance our Biotech manufacturing capability at our Bacchus Marsh facility in Victoria. The grant will supplement our recent capital raise to advance our Biotech business, and free up existing resources, which will be focused on our Advanced Batteries development.

Our development of crop protection products, marine coatings and potential future applications in health and pharmaceuticals will benefit greatly from this assistance.

We thank the Australian Government for its support of Australian manufacturing industries which will assist the development of high value products for domestic and export markets.” Phil Hodgson, CEO and MD. 

SUBSCRIBE TO OUR NEWSLETTER

  • Hidden
  • Hidden
  • This field is for validation purposes and should be left unchanged.
YouTube
LinkedIn
Share